Media Center
Press Releases
INVESTOR BRAND NETWORK LOS ANGELES, April 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting companies to the investment community through 50+ brands, today announced it will partner with Dynamic Global Events (“DGE”) as an official media partner for upcoming events in 2021. BioMedWire (“BMW”), a specialized communications platform for the life sciences sector and one of the 50+ brands part of the InvestorBrandNetwork, is also joining as an official media partner for DGE’s upcoming events.
INVESTORWIRE Lifescience and pharma professionals are invited to attend the 2nd Rx to OTC symposium being held on November 11-12, 2021. The online event is hosted by Dynamic Global Events (“DGE”), a global event company that caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.
INVESTORWIRE Lifescience and healthcare professionals across all department functions, and consultants are invited to attend DGE’s Advancing Diversity, Equity & Inclusion (“DEI”) In Pharma & Healthcare Conference, streaming live online November 4-5, 2021.
INVESTORWIRE Dynamic Global Events (“DGE”) is proud to announce its 2nd Risk Evaluation and Mitigation Strategies (“REMS”) virtual summit. This two-day event, scheduled for October 11-12, 2021, will be an excellent avenue for life science professionals to develop decision making skills to adapt to anticipate FDA feedback with ease. This virtual conference is an exceptional resource for gaining new insights into adapting to risk mitigation strategies regarding submissions and modifications.
INVESTORWIRE Pharma professionals, healthcare providers, influencers, and healthcare-related industries are invited to attend DGE’s 7th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare being held on September 22-24, 2021, as a live online event. The event is organized by Dynamic Global Events (“DGE”), a Life Science leader in hosting B2B events. This global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.
INVESTORWIRE Dynamic Global Events (“DGE”) invites biopharma and medical device industry professionals to join them online September 16-17, 2021, for the 2nd Clinical Trial Agreements Conference. DGE’s first event was held online earlier this year and was focused greatly on the COVID-19 pandemic, the confidentiality of subject data, and the increased use of telemedicine, among other topics. The first event helped industry professionals determine what needed to be considered before entering into a clinical trial agreement.
INVESTORWIRE Professionals and executives in pharmaceutical, biotech, and medical device companies are invited to attend DGE’s 2nd Human Factors Engineering & Usability Studies Congress being held on September 9-10, 2021. The leading industry conference will offer an educational experience on designing and testing safe and intuitive medical products for all user groups while adapting to regulatory compliance and the unpredictable post-COVID pandemic impact.
INVESTORWIRE Pharmaceutical, biotech, and medical device professionals/employees are invited to attend DGE’s Pharma Employee Engagement & Experience Summit on August 30-31, 2021. The Summit will concentrate on core areas to cultivate positives, maintain trust, and prioritize equity to achieve a safe, productive workforce experience. The conference will address the most vital employee engagement concerns, guided by valuable inputs from pharma leaders and thinkers who will share their insights and opinions in the 2-day event.
INVESTORWIRE Medical professionals are invited to attend DGE’s Blockchain Pharma & Life Sciences Summit on August 23-24, 2021 to learn successful strategies of successfully using the decentralized technology to boost trust and improve transparency throughout the life science ecosystem including regulators, contract manufacturers, physicians, and patients.
INVESTORWIRE Clinical researchers, medical managers, pharma companies, and life science professionals are invited to attend the 2nd Electronic Trial Master File (“eTMF”) Forum on August 16-17th, 2021. This 2-day event will offer a leading stage to learn the skills of integrated TMF technology for successful clinical research. Attendees will understand the intricacies of identifying the challenges and risks posed during clinical research. They will learn to identify how to protect the data gathered during the research trials, meeting regulatory requirements, preparing for audits, getting ready for inspections, and lucrative techniques for monitoring and filing correspondence.
INVESTORWIRE On July 28-30, 2021, medical officers and healthcare professionals are invited to attend DGE’s 4th Digital & Innovation For Medical Affairs Summit to learn and upskill with the progressive technologies and novel policies of the digital era. This online live streaming event is organized by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The Global Event Company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.
INVESTORWIRE Chief Patient officers and leaders of engagement, advocacy, communications and support services, are invited to attend the inaugural Chief Patient Officer Summit on July 22-23, 2021, organized by DGE. This online live streaming event is driven to focus on opportunities and challenges faced by Chief Patient officers and executives while offering a seamless patient experience.
BIOMEDWIRE Biopharma medical writing and communications professionals are invited are invited to attend DGE’s 2nd Medical Writing Innovation Strategies Conference for Life Sciences live streaming on June 29-30, 2021. The event will offer useful tips and guide medical professionals to learn innovative skills for filtering technical information that is effectively communicated for engagement.
INVESTOR BRAND NETWORK Medical Science Liaisons (MSLs), along with pharma companies and other life science professionals, are invited to attend DGE’S inaugural Next-Gen MSL Excellence Symposium being held on June 23-24, 2021. This symposium is the only virtual industry event to focus on the work challenges faced by MSLs, to emphasize the importance of their role in drug and device development and adapting to new technologies in the Post-COVID scenario.
INVESTOR BRAND NETWORK The COVID-19 impact has brought a paradigm shift in the responsibilities of medical professionals. This ‘new normal’ requires updates and revised training of medical professionals to adapt to the new hybrid work environment.
INVESTOR BRAND NETWORK As marketing gets personalized and consumers expect to be reached on their channel of preference, pharma companies are spending significantly on marketing and sales. On June 10-11, 2021, life science professionals are invited to attend DGE’s Omnichannel Marketing Strategy Symposium to learn skills and techniques for developing a personalized marketing strategy for consumers.
INVESTOR BRAND NETWORK The worldwide impact of COVID-19 has shifted the landscape of clinical trials forever. On June 3-4 2021, biopharmaceutical and medical device companies are invited to attend the Live Streaming of the Risk-Based Quality Management Summit. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events.
INVESTOR BRAND NETWORK As the impact of COVID-19 is felt stronger than ever, the need for virtual clinical trials is now more essential, than ever. In wake of the rising need for virtual clinical trials.  The 4th Virtual Clinical Trials conference will be live-streamed on 17 18TH May 2020. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events.
INVESTORWIRE Described as relatable, dynamic, passionate, and inspirational, Colleen Hauk – the event’s speaker – has made a name for herself as a seasoned trainer, speaker, and co-author of two books. Colleen always seeks to empower her audiences and clients to expand their minds beyond what is expected so that they can strike a balance between leadership and their personal lives. She has delivered trainings and keynotes to various renowned organizations, including Panasonic, Dell, Coldwell Banker, US Foods, and more (
INVESTOR BRAND NETWORK The COVID-19 fear increases as the pandemic spreads its way into the second year of impacting people’s day-to-day affairs, not only in the United States but throughout the world,  the role of KOLs becomes even more important role in each stage of the drug life cycle. The KOL & Thought Leader Engagement Summit will commence as a live streaming event on 28th-29th April.
BIOMEDWIRE Companies view mergers and acquisitions (“M&A”) as opportunities to broaden their portfolio, expand to international markets and increase leverage and scale. In the MedTech industry, in particular, companies look at M&A as an opportunity to drive positive financial growth and enhance therapeutic solutions (, as well as to address industry changes such as those brought by newly introduced regulations, slowed health care spending, negative pricing trends or, more recently, the pandemic.
MCDERMOTT WILL & EMERY The US Food and Drug Administration (FDA) became a central focus of US and global attention in 2020, since the agency regulates many of the therapies, treatments and interventions necessary to mitigate and combat the COVID-19 pandemic. The agency faced many challenges in light of the inevitable politicization of a public health emergency, exercising rarely used authorities to facilitate an expedient response to the pandemic in addition to pushing forward its traditional regulatory agenda.
MONOCL External experts are sought-after advisors for life science companies, where they inform critical decisions along the entire product lifecycle of a drug. These experts use the knowledge and experience they acquired over the course of their careers to help companies address challenges like identifying unmet medical needs, clinical trial design, stratification of patient populations, label extensions, product positioning, regulatory challenges and many others. They can also serve as the scientific face of the organization, e.g. by discussing trial results during conferences and/or co-authoring scientific publications.
San Francisco, CA (December 9, 2020) - Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced that Clovis Oncology has selected Alucio’s Beacon as its scientific exchange platform. Beginning in January 2021, Beacon will be used by Clovis medical affairs to manage medical and scientific content for field use, and enable their medical science liaisons (MSLs) to more effectively engage with healthcare professionals (HCPs) both in the US and Europe.
San Francisco, CA (November 10, 2020) -Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced the release of new features for Beacon’s mobile phone users. These enhancements optimize the user experience for meeting attendees participating in virtual scientific exchanges on their smartphones.
San Francisco, CA (September 24, 2020) - Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, announced today that it has joined The Board Challenge ( initiative created to improve the representation of Black directors in corporate US boardrooms. Companies taking The Board Challenge pledge commit to adding a Black director to their board within the next year.
Many of us spend hours in back-to-back virtual meetings these days. While these video engagements are convenient and relatively simple to set up, they also bring a number of challenges for presenters – including for those delivering scientific content and engaging with healthcare professionals (HCPs).